腎結石管理市場、機會、成長動力、產業趨勢分析與預測，2024-2032

2023年全球腎結石管理市場價值約26億美元，預計2032年將成長至41億美元左右，複合年成長率為5.1%。這種成長主要是由於腎結石患病率的增加、高復發率以及先進治療技術解決方案的不斷開發所推動的。由於人口老化和生活方式因素（例如高鹽、蛋白質和草酸鹽的飲食），腎結石在通過尿道時會引起嚴重疼痛，因此變得越來越常見。

腎結石管理涉及一系列旨在減少結石形成的醫療治療、診斷工具和預防策略。市場按結石類型細分，其中以草酸鈣結石最為普遍，佔結石病例的 75-80%。 2023年，草酸鈣細分市場創造了19億美元的收入。這些結石的危險因子包括富含草酸鹽的飲食，例如菠菜和堅果，以及高鈣攝取量。

該市場的診斷包括腹部 X 光檢查、CT 掃描、超音波、MRI 和靜脈腎盂造影。 CT scans led the market in 2023, and their popularity is expected to continue growing, with a projected market value of USD 1.3 billion by 2032. The appeal of CT scans lies in their rapid, non-invasive nature, making them particularly useful in emergency設定.

腎結石的治療方法包括體外震波碎石術（ESWL）、輸尿管鏡檢查和經皮腎鏡取石術（PCNL）。 2023年ESWL佔據市場主導地位，佔58.2%的市佔率。這種非侵入性技術使用衝擊波來分解結石，以便更容易通過，對草酸鈣和尿酸等結石特別有效。

醫院是腎結石管理市場最大的最終用戶，到2023 年將產生13 億美元的收入。腎結石管理市場的關鍵驅動力。

從地區來看，北美在 2023 年以 11 億美元的價值引領市場。該地區腎結石的高盛行率歸因於飲食和生活方式因素。此外，該地區先進的醫療基礎設施支援全面的腎結石管理。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 全球腎結石盛行率和復發率不斷上升
    • 輸尿管鏡技術的進步
    • 碎石手術的優惠報銷
    • 傾向接受微創手術
    • 人們對整體腎臟健康的認知不斷提高
  • 產業陷阱與挑戰
    • 某些國家缺乏治療意識
    • 碎石術的潛在長期不良影響
• 成長潛力分析
• 技術景觀
• 未來市場趨勢
• 監管環境
• 報銷場景
• 差距分析
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按類型，2021 - 2032

• 主要趨勢
• 草酸鈣
• 磷酸鈣
• 尿酸
• 鳥糞石
• 半胱胺酸

第 6 章：市場估計與預測：透過診斷，2021 - 2032

• 主要趨勢
• 腹部 X 光檢查
• 電腦斷層掃描
• 超音波
• 腹部核磁共振檢查
• 靜脈腎盂造影
• 其他診斷

第 7 章：市場估計與預測：按處理方式，2021 - 2032

• 主要趨勢
• 腹部 X 光檢查
• 體外震波碎石術（ESWL）
• 輸尿管鏡檢查
• 經皮腎鏡取石術（PCNL）
• 其他治療

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

• 主要趨勢
• 醫院
• 專科診所
• 門診手術中心
• 其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 南非
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 10 章：公司簡介

• Allengers Medical Systems Ltd
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Coloplast A/S
• Cook Medical LLC
• DirexGroup
• Dornier MedTech
• EDAP TMS SA
• Elmed Medical Systems
• Karl Storz GmbH
• Medispec Ltd
• Olympus Corporation
• Richard Wolf GmbH
• Siemens Healthineers

The Global Kidney Stone Management Market was valued at approximately USD 2.6 billion in 2023 and is projected to grow to around USD 4.1 billion by 2032, with a CAGR of 5.1%. This growth is largely driven by the increasing prevalence of kidney stones, their high recurrence rates, and the ongoing development of advanced technological solutions for treatment. Kidney stones, which can cause significant pain as they move through the urinary tract, are becoming more common due to aging populations and lifestyle factors, such as diets high in salt, protein, and oxalates.

Kidney stone management involves a range of medical treatments, diagnostic tools, and preventative strategies aimed at reducing stone formation. The market is segmented by stone type, with calcium oxalate stones being the most prevalent, representing 75-80% of cases. In 2023, the calcium oxalate segment generated USD 1.9 billion in revenue. Risk factors for these stones include diets rich in oxalates, such as spinach and nuts, along with high calcium intake.

Diagnostics in this market include abdominal x-rays, CT scans, ultrasounds, MRIs, and intravenous pyelography. CT scans led the market in 2023, and their popularity is expected to continue growing, with a projected market value of USD 1.3 billion by 2032. The appeal of CT scans lies in their rapid, non-invasive nature, making them particularly useful in emergency settings.

Treatment methods for kidney stones include extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, and percutaneous nephrolithotomy (PCNL). ESWL dominated the market in 2023, accounting for 58.2% of the market share. This non-invasive technique uses shock waves to break down stones for easier passage and is especially effective for stones like calcium oxalate and uric acid.

Hospitals were the largest end use rs in the kidney stone management market, generating USD 1.3 billion in 2023. Hospitals are equipped to handle emergencies such as acute renal colic and offer advanced technologies, such as laser lithotripters and surgical robots, which are key drivers for this segment.

Regionally, North America led the market in 2023 with a value of USD 1.1 billion. The region's high prevalence of kidney stones is attributed to dietary and lifestyle factors. Additionally, the region's advanced healthcare infrastructure supports comprehensive kidney stone management.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence and recurrence rate of kidney stones globally
    • 3.2.1.2 Advancements in ureteroscopy technique
    • 3.2.1.3 Favourable reimbursement for lithotripsy procedures
    • 3.2.1.4 Inclination towards undergoing minimally invasive surgeries
    • 3.2.1.5 Rising awareness regarding overall kidney health
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of treatment awareness in certain countries
    • 3.2.2.2 Potential long-term adverse effects of lithotripsy
• 3.3 Growth potential analysis
• 3.4 Technology landscape
• 3.5 Future market trends
• 3.6 Regulatory landscape
• 3.7 Reimbursement scenario
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Calcium oxalate
• 5.3 Calcium phosphate
• 5.4 Uric acid
• 5.5 Struvite
• 5.6 Cysteine

Chapter 6 Market Estimates and Forecast, By Diagnostics, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Abdominal x-ray
• 6.3 Computed tomography
• 6.4 Ultrasound
• 6.5 Abdominal MRI
• 6.6 Intravenous pyelography
• 6.7 Other diagnostics

Chapter 7 Market Estimates and Forecast, By Treatment, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Abdominal x-ray
• 7.3 Extracorporeal shock wave lithotripsy (ESWL)
• 7.4 Ureteroscopy
• 7.5 Percutaneous nephrolithotomy (PCNL)
• 7.6 Other treatments

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Specialty clinics
• 8.4 Ambulatory surgical centers
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Allengers Medical Systems Ltd
• 10.2 Becton, Dickinson and Company
• 10.3 Boston Scientific Corporation
• 10.4 Coloplast A/S
• 10.5 Cook Medical LLC
• 10.6 DirexGroup
• 10.7 Dornier MedTech
• 10.8 EDAP TMS S.A
• 10.9 Elmed Medical Systems
• 10.10 Karl Storz GmbH
• 10.11 Medispec Ltd
• 10.12 Olympus Corporation
• 10.13 Richard Wolf GmbH
• 10.14 Siemens Healthineers